DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
>
> This Story

Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

Siemens Healthineers announces the expansion of its Ottawa manufacturing facility

CVS Health acquisition of Aetna moving forward on agreement with U.S. Department of Justice

Quest Diagnostics to sell India diagnostics business to Strand Life Sciences

GHX says collaboration critical to advance clinically integrated supply chains

Radiology Partners continues growth in Florida through partnership with Mori, Bean & Brooks

Icahn School of Medicine at Mount Sinai to hosts seventh annual SINAInnovations Festival and third Health Hackathon

Alberta Health Services deploys MEDITECH throughout five public health zones

Emory University study demonstrates that educational videos significantly improve patient consent process and save time

Pacific Health Care Organization begins strategic acquisition search aimed at revolutionizing the workers' compensation industry

AstraZeneca well placed to use Medtech to expand in Chinese healthcare market, says GlobalData

Cerveau Technologies signs research agreement with KU Leuven University in Belgium

Press releases may be edited for formatting or style
BOSTON--(BUSINESS WIRE)--Cerveau Technologies Inc. today announced an agreement with the KU Leuven university in Belgium to support multiple projects over the next several years. These research projects are for studies of an early stage imaging agent (MK-6240) to be used in Positron Emission Tomography (PET) scans for assessing the status and progression of neurofibrillary tangles (NFTs) in the brain. NFTs made up of aggregated tau protein are a hallmark of several neurodegenerative diseases, including Alzheimer’s disease.

As part of the agreement, Cerveau will contract with KU Leuven to manufacture and supply the [18F]MK-6240 needed for initiatives in the Belgium area.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



According to Professor Koen Van Laere from the Nuclear Medicine Division at KU Leuven “We have conducted the first-in-man studies with this highly specific tau imaging compound MK-6240 that allows imaging and quantification of the spread of tau pathology in the living human brain using positron emission tomography-PET. From these initial studies it was already clear that this compound offers unique possibilities to selectively measure tau deposition and its consequences. It is of high interest in various brain disorders that may even go beyond Alzheimer’s disease, such as stroke and traumatic brain injury. We want to investigate how we can use MK-6240 to predict and monitor disease disability and help develop new drug treatments.”

“Cerveau welcomes this opportunity to continue working with the KU Leuven researchers to understand the application of MK-6240 and how it may benefit patients with brain diseases. The collaboration with KU Leuven will provide access to our pharmaceutical partners in support of various therapy trials and support our global production network in Europe, Canada, Japan, China, Singapore, Australia and the United States as well facilitate novel research at KU Leuven in the pursuit of evaluating potential preventive treatment options for Alzheimer’s disease,” said Rick Hiatt, President and CEO of Cerveau Technologies, Inc.

About KU Leuven and Leuven University Hospital

KU Leuven is an institution for research and education with international appeal. All programmes at this University are based on the innovative research of its scientists and professors. Specifically, KU Leuven and Leuven University Hospital aim to introduce innovative approaches into cutting edge patient care and have strongly invested in state-of-the-art radiotracer production facilities and multimodal PET scanners. KU Leuven ranks among the best 50 universities worldwide and leads the Reuters ranking of Europe’s most innovative universities.

About Cerveau Technologies, Inc.

Cerveau Technologies, Inc. is a partnership between Enigma Biomedical Group, Inc. and Sinotau Pharmaceutical Group. Cerveau's vision is to globally develop diagnostics and technology that positively impact patients with neurodegenerative disorders including Alzheimer's disease.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2018 DOTmed.com, Inc.
版权所有